Krishna Patel, PA
Medical · Roswell, GANPI 1265064901
Payments from drug & device makers
Across 17 payments — averaging $24.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$99
- Sanofi$76
- Collegium Pharmaceutical, Inc.$53
- Takeda Pharmaceuticals U.S.A., Inc.$48
- Travere Therapeutics, Inc.$48
- Pfizer$41
- plus $46 from 2 others
What the payments were for
- Food & beverage$31076%
- Education$9924%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 1 | $99 |
| Sanofi | 4 | $76 |
| Collegium Pharmaceutical, Inc. | 3 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| Travere Therapeutics, Inc. | 3 | $48 |
| Pfizer | 2 | $41 |
| AbbVie | 1 | $26 |
| Hikma Pharmaceuticals USA | 1 | $20 |
How this compares
$410 in reported general payments places this provider in the 40th percentile of 950 medical providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 55 | $9,617 |
| MovantikNaloxegol Oxalate | 14 | $5,720 |
| Naloxone Hcl | 43 | $2,930 |
| Gabapentin | 190 | $2,356 |
| Cyclobenzaprine Hcl | 66 | $927 |
| Tizanidine Hcl | 82 | $862 |
| Lidocaine | 12 | $717 |
| Promethazine Hcl | 27 | $682 |
| Duloxetine Hcl | 17 | $358 |
| Pregabalin | 20 | $276 |
| Ondansetron Hcl | 14 | $202 |
| Atorvastatin Calcium | 28 | $175 |
| Amlodipine Besylate | 32 | $153 |
| Baclofen | 18 | $147 |
| Meloxicam | 37 | $132 |
Paid to pharmacies, not to this prescriber.
Other medical in Roswell
- Felicia HoffmanRoswell$114K
- Tomas ChaoWoodstock$1.9M
- Kimberly OrleckAtlanta$727K
- Audrey GibsonGainesville$302K
- Lisa WeissCanton$283K
- Laura BushFayetteville$146K
- Michael KelleherMarietta$126K
- Juliena GigonMarietta$122K
- Sally BrumbillLithia Springs$110K
- Danna Dennis-CalderAtlanta$87K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.